All blog posts
Total 167 results for
Showing 12 out of 167 results
27 avril 2026
The EU Pharma Package is finally here – here's the settled position on key areas
12 mars 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
19 janvier 2026
Where is the UPC after two and a half years - and what to expect in 2026?
15 décembre 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
26 novembre 2025
FRAND interim licensing – where are the limits?
03 septembre 2025
UPC Court of Appeal confirms that late-filed costs applications are inadmissible and in refusing reference to the CJEU provides guidance on what it will refer
31 juillet 2025
EU Regulatory Reform for Medicinal Products: Bolar exemption
21 juillet 2025
Trends emerging as the UPC enters its third year
13 mai 2025
EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency
30 avril 2025
EU Regulatory Reform for Medicinal Products: Review of new regulatory exclusivities
12 février 2025
European Commission shelves proposed SEP regulation
05 novembre 2024
Regulation of SEPs in Europe – where are we now?
Showing 12 out of 167 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London